Abbott India Limited (BOM:500488)
26,340
-253 (-0.95%)
At close: Nov 6, 2026
Abbott India Revenue
Abbott India had revenue of 20.19B INR in the quarter ending September 30, 2026, with 14.91% growth. This brings the company's total for the last twelve months to 71.99B, up 7.22% year-over-year. In the fiscal year ending March 31, 2026, Abbott India had annual revenue of 69.29B with 8.11% growth. That makes Abbott India the 9,105th largest company in the world by revenue and 363rd in India.
Revenue (ttm)
71.99B
Revenue Growth
+7.22%
P/S Ratio
7.77
Revenue / Employee
19.57M
Employees
3,679
Market Cap
559.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 69.29B | 5.20B | 8.11% |
| Mar 31, 2025 | 64.09B | 5.60B | 9.58% |
| Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
| Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
| Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 329.84B |
| Lupin | 307.46B |
| Torrent Pharmaceuticals | 174.00B |
| Jubilant Pharmova | 86.08B |
| Granules India | 58.93B |
| GlaxoSmithKline Pharmaceuticals | 41.98B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| Viyash Scientific | 35.75B |
Abbott India News
- 1 day ago - Abbott India Quarterly report: Q2 2027 - Filings
- 2 months ago - Abbott India Quarterly report: Q1 2027 - Filings
- 5 months ago - Abbott India Quarterly report: Q4 2026 - Filings
- 5 months ago - Abbott India Annual report: Q4 2026 - Filings
- 7 months ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 8 months ago - Abbott India Quarterly report: Q3 2026 - Filings
- 1 year ago - Abbott India Quarterly report: Q2 2026 - Filings
- 1 year ago - Abbott India Quarterly report: Q1 2026 - Filings